Replies to post #4494 on Halozyme Therapeutics Inc (HALO)

[maumar]

"I think we exceed that in 2017."

I certainly hope you are right. That would be fantastic growth and you make a good case for it. It's quite possible the market hasn't figured this out yet. If you are right, shouldn't Halo's market cap be at least $2B just on the basis of Enhanze? The only legitimate concern is a certain lack of visibility. When will Herceptin and Mabthera become obsolete and what will replace them?

Can we get to $200M in royalties in 2020?